Microbix Biosystems Inc. (MBXBF)
MBXBF Stock Price Chart
Explore Microbix Biosystems Inc. interactive price chart. Choose custom timeframes to analyze MBXBF price movements and trends.
MBXBF Company Profile
Discover essential business fundamentals and corporate details for Microbix Biosystems Inc. (MBXBF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Jan 2021
Employees
100.00
Website
https://microbix.comCEO
Cameron L. Groome
Description
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
MBXBF Financial Timeline
Browse a chronological timeline of Microbix Biosystems Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 11 Feb 2026
Upcoming earnings on 17 Dec 2025
Earnings released on 14 Aug 2025
EPS came in at -$0.01 , while revenue for the quarter reached $2.55M , missing expectations by -2.21%.
Earnings released on 15 May 2025
EPS came in at $0.00 , while revenue for the quarter reached $3.74M , beating expectations by +20.85%.
Earnings released on 12 Feb 2025
EPS came in at $0.00 , while revenue for the quarter reached $4.20M , beating expectations by +3.96%.
Earnings released on 19 Dec 2024
EPS came in at $0.00 , while revenue for the quarter reached $18.71M , beating expectations by +352.13%.
Earnings released on 7 Aug 2024
EPS came in at $0.00 , while revenue for the quarter reached $3.70M , missing expectations by -7.92%.
Earnings released on 15 May 2024
EPS came in at $0.00 , while revenue for the quarter reached $4.15M , beating expectations by +10.18%.
Earnings released on 27 Mar 2024
EPS came in at $0.01 , while revenue for the quarter reached $6.33M , beating expectations by +3.58%.
Earnings released on 21 Dec 2023
EPS came in at $0.01 surpassing the estimated -$0.00 by +1.56K%, while revenue for the quarter reached $3.15M , missing expectations by -10.90%.
Earnings released on 10 Aug 2023
EPS came in at -$0.00 , while revenue for the quarter reached $4.17M , beating expectations by +15.29%.
Earnings released on 16 May 2023
EPS came in at -$0.00 surpassing the estimated -$0.00 by +70.95%, while revenue for the quarter reached $3.12M , missing expectations by -10.58%.
Earnings released on 9 Feb 2023
EPS came in at -$0.01 falling short of the estimated -$0.00 by -549.35%, while revenue for the quarter reached $1.86M , missing expectations by -35.10%.
Earnings released on 22 Dec 2022
EPS came in at -$0.01 falling short of the estimated -$0.00 by -400.00%, while revenue for the quarter reached $3.16M , missing expectations by -16.91%.
Earnings released on 11 Aug 2022
EPS came in at $0.00 falling short of the estimated $0.00 by -20.00%, while revenue for the quarter reached $3.89M , missing expectations by -7.20%.
Earnings released on 12 May 2022
EPS came in at $0.01 falling short of the estimated $0.02 by -58.33%, while revenue for the quarter reached $3.90M , missing expectations by -17.63%.
Earnings released on 10 Feb 2022
EPS came in at $0.01 falling short of the estimated $0.02 by -40.01%, while revenue for the quarter reached $3.81M , missing expectations by -4.62%.
Earnings released on 23 Dec 2021
EPS came in at $0.01 surpassing the estimated $0.01 by +11.11%, while revenue for the quarter reached $4.44M .
Earnings released on 12 Aug 2021
EPS came in at $0.01 surpassing the estimated $0.01 by +57.23%, while revenue for the quarter reached $4.40M .
Earnings released on 13 May 2021
EPS came in at $0.01 , while revenue for the quarter reached $3.46M .
Earnings released on 11 Feb 2021
EPS came in at $0.00 , while revenue for the quarter reached $2.47M .
Earnings released on 18 Dec 2020
EPS came in at -$0.05 falling short of the estimated -$0.01 by -600.28%, while revenue for the quarter reached $2.03M .
MBXBF Stock Performance
Access detailed MBXBF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.